BioSpace News Archive

Genetown

Rhythm Pharmaceuticals Announces Early Access Authorization for Setmelanotide for Use in Patients with Bardet-Biedl Syndrome in France

Rhythm Pharmaceuticals, Inc. today announced that the French National Agency for Medicines and Health Products Safety (ANSM) and Haute Autorité de santé (HAS) have granted pre-marketing authorization AP1 (autorisation d’accès précoce - early access authorization),

July 20, 2022
·
9 min read
Business

DLH to Announce Fiscal 2022 Third Quarter Financial Results

DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading healthcare and human services provider to the federal government, will release financial results for its fiscal third quarter ended June 30, 2022 on August 2, 2022 after the market closes.

July 20, 2022
·
1 min read
Business

SeaStar Medical Submits Humanitarian Device Exemption Application to FDA for Use of Selective Cytopheretic Device in Children with Acute Kidney Injury Application

SeaStar Medical and LMF Acquisition Opportunities, Inc. today announced SeaStar Medical has submitted its application to the U.S. Food and Drug Administration (“FDA”) for Humanitarian Device Exemption (HDE).

July 20, 2022
·
10 min read
Business

ProKidney Appoints Kerry Cooper, M.D., as Senior Vice President of Medical AffairsExtensive Nephrology Medical Affairs Leadership and Clinical Practice Expertise Brought to ProKidney

ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cellular therapeutics company focused on Chronic Kidney Disease (CKD), announces the appointment of nephrologist Kerry Cooper, M.D. as Senior Vice President of Medical Affairs.

July 20, 2022
·
6 min read
AIM ImmunoTech reports additional patient data from Single-Center Named Patient Program evaluating Ampligen

AIM ImmunoTech Inc. today reported follow-on data from its previously published single-center named patient program.

July 20, 2022
·
6 min read
ForSight Robotics Raises $55 Million in Series A Round to Develop World’s First Fully Robotic Cataract Surgery Procedure

ForSight Robotics, the pioneer in ophthalmic robotic surgery, today announced it completed a $55 million Series A round to advance the world’s first surgical platform for fully robotic cataract surgery: ORYOM.

July 20, 2022
·
7 min read
Business

NexusBioAg and MustGrow Biologics Announce Exclusive Marketing and Distribution Agreement in Canada

Univar Solutions Inc. (NYSE: UNVR) (“Univar Solutions”), announced today that NexusBioAg, have reached an exclusive marketing and distribution agreement in the Canadian canola and pulse market for TerraMG™, a mustard-derived soil biopesticide technology.

July 20, 2022
·
11 min read
Drug Development

Aytu BioPharma Announces Initiation of the AR101 PREVEnt Trial for the Treatment of Vascular Ehlers-Danlos Syndrome

Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced the initiation of the global Phase 3.

July 20, 2022
·
5 min read
Nanostics Announces the Launch of its Bladder Cancer Clinical Study to Identify the Most Potent Disease Predictors for Early Detection of Bladder Cancer

Nanostics Inc., a precision health diagnostics company, is excited to launch a prospective clinical study designed to validate a novel and minimally invasive bladder cancer diagnostic test, ClarityDX Bladder, using its ClarityDX® diagnostic platform.

July 20, 2022
·
3 min read
Business

New Collaborative Research Study Between nference and the NIH Identifies Which Mutations Enable Highly Transmissible Viruses, Like SARS-CoV-2, to Persist in Human Circulation

nference , an AI-driven health technology company, today announced a new research partnership following the publication of a study demonstrating the value of characterizing SARS-CoV-2 viral sequences using its newly introduced ‘Distinctiveness’ metric.

July 20, 2022
·
4 min read